SERB SA

SERB SA is a pharmaceutical company that specializes in the development, manufacturing, and distribution of specialized medicines, particularly in the areas of emergency care, critical care, and rare diseases. SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks, making them a trusted partner and one-stop-shop for hospitals, emergency services, health departments, and governments.